Showing results (661-670 of 671) with videos related to

Sort By:
Pageof 68
Diabetology International|May 18, 2026
Correction: A case-control study on the prevalence of depression and its biomarkers in Type 2 diabetes mellitus patientsHaya Majid, Sajad Ul Islam, Sunil Kohli, et al.
Diabetology International|May 18, 2026
Minimal change disease in a patient with type 1 diabetes and Crohn's disease managed with advanced hybrid closed-loop insulin therapy during corticosteroid treatmentAtsushi Sato, Nozomi Harai, Ryutaro Fumoto, et al.
Diabetology International|October 9, 2019
Clinical background of Japanese patients with type 1 diabetes mellitus who have received insulin therapy for 50 years or longerToshika Otani, Tadasu Kasahara, Junnosuke Miura, et al.
Diabetology International|May 25, 2026
Correction: Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetesMizuki Ishiguro, Rimei Nishimura
Diabetology International|October 2, 2023
Lifestyle behaviors that reduce food and fat intake in patients with type 2 diabetes within 3 months of diagnosis lead to a reduction in the HbA1c level after 12 monthsYuri Tokunaga-Nakawatase, Maki Aomori, Setsuko Watabe
Diabetology International|June 8, 2026
Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic careShambo Samrat Samajdar, Shashank Joshi, Banshi Saboo, et al.
Diabetology International|June 8, 2026
Phase angle, extracellular to intracellular water ratio, and advanced glycation end products according to four sarcopenia categories and in relation to muscle strength/mass in elderly out-patients with diabetesToshihiro Amagawa, Hiroki Yokoyama, Yumiko Teramoto, et al.
Diabetology International|January 4, 2019
Loss of skeletal muscle mass and its predictors in type 2 diabetes patients under a multifaceted treatment approachNorihiko Ohara, Isao Minami, Ryotaro Bouchi, et al.
Diabetology International|February 26, 2019
Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in JapanNobuo Matsuura, Shin Amemiya, Shigetaka Sugihara, et al.
Diabetology International|September 3, 2026
Prevalence, severity, and risk factors of lipohypertrophy in Japanese with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections: the CSII-LH cross-sectional studySeiko Sakane, Masayuki Domichi, Akiko Suganuma, et al.
Pageof 68